1-7 of 7
Wolfram Brugger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 311: Development of AZD2811, an aurora kinase B inhibitor, incorporated into an AccurinTM nanoparticle for use in haematological and solid cancers

Susan Ashton, Nicholas Floch, Paula Taylor, Colin Howes, Doug Ferguson, Matthew Ling, Maureen Hattersley, Shenghua Wen, Kim Maratea, Adina Hughes, Sean Redmond, Wolfram Brugger, Simon Smith, Alexander MacDonald, Keith Parry, Howard Burris, Young-Ho Song, Jim Nolan, Elizabeth Pease, Simon T. Barry
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 311.
https://doi.org/10.1158/1538-7445.AM2017-311
Published: 01 July 2017
View articletitled, Abstract 311: Development of AZD2811, an aurora kinase B inhibitor, incorporated into an AccurinTM nanoparticle for use in haematological and solid cancers
Journal Articles

Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide

Steffen Walter, Toni Weinschenk, Arnulf Stenzl, Romuald Zdrojowy, Anna Pluzanska, Cezary Szczylik, Michael Staehler, Wolfram Brugger, Pierre-Yves Dietrich, Norbert Hilf, Oliver Schoor, Jens Fritsche, Andrea Mahr, Regina Mendrzyk, Dominik Maurer, Verona Vass, Claudia Trautwein, Peter Lewandrowski, Christian Flohr, Heike Pohla, Janusz J. Stanczak, Vincenzo Bronte, Susanna Mandruzzato, Tilo Biedermann, Graham Pawelec, Evelyna Derhovanessian, Hisakazu Yamagishi, Tsuneharu Miki, Fumiya Hongo, Natsuki Takaha, Kosei Hirakawa, Hiroaki Tanaka, Stefan Stevanovic, Hans-Georg Rammensee, Jürgen Frisch, Andrea Mayer-Mokler, Alexandra Kirner, James Finke, Brian Rini, Carsten Reinhardt, Harpreet Singh
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 5365.
https://doi.org/10.1158/1538-7445.AM2012-5365
Published: 15 April 2012
View articletitled, Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide
Journal Articles

Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients

Jan Wierecky, Martin R. Müller, Stefan Wirths, Edith Halder-Oehler, Daniela Dörfel, Susanne M. Schmidt, Maik Häntschel, Wolfram Brugger, Stephen Schröder, Marius S. Horger, Lothar Kanz, Peter Brossart
Journal: Cancer Research
Cancer Res (2006) 66 (11): 5910–5918.
https://doi.org/10.1158/0008-5472.CAN-05-3905
Published: 01 June 2006
View articletitled, Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients
Open the PDF for Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients in another window
Includes: Supplementary data
Journal Articles

The Epithelial Tumor Antigen MUC1 Is Expressed in Hematological Malignancies and Is Recognized by MUC1-specific Cytotoxic T-Lymphocytes

Peter Brossart, Anya Schneider, Patricia Dill, Theodora Schammann, Frank Grünebach, Stefan Wirths, Lothar Kanz, Hans-Jörg Bühring, Wolfram Brugger
Journal: Cancer Research
Cancer Res (2001) 61 (18): 6846–6850.
Published: 01 September 2001
View articletitled, The Epithelial Tumor Antigen MUC1 Is Expressed in Hematological Malignancies and Is Recognized by MUC1-specific Cytotoxic T-Lymphocytes
Open the PDF for The Epithelial Tumor Antigen MUC1 Is Expressed in Hematological Malignancies and Is Recognized by MUC1-specific Cytotoxic T-Lymphocytes in another window
Journal Articles

Tumor Necrosis Factor α and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells

Peter Brossart, Anke Zobywalski, Frank Grünebach, Lars Behnke, Gernot Stuhler, Volker L. Reichardt, Lothar Kanz, Wolfram Brugger
Journal: Cancer Research
Cancer Res (2000) 60 (16): 4485–4492.
Published: 01 August 2000
View articletitled, Tumor Necrosis Factor α and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells
Open the PDF for Tumor Necrosis Factor α and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells in another window
Journal Articles

Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes

Peter Brossart, Gernot Stuhler, Thomas Flad, Stefan Stevanovic, Hans-Georg Rammensee, Lothar Kanz, Wolfram Brugger
Journal: Cancer Research
Cancer Res (1998) 58 (4): 732–736.
Published: 01 February 1998
View articletitled, Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes
Open the PDF for Her-2/neu-derived Peptides Are Tumor-associated Antigens Expressed by Human Renal Cell and Colon Carcinoma Lines and Are Recognized by in Vitro Induced Specific Cytotoxic T Lymphocytes in another window
Journal Articles

Adoptive Transfer of Tumor Cytotoxic Macrophages Generated in Vitro from Circulating Blood Monocytes: A New Approach to Cancer Immunotherapy

Reinhard Andreesen, Carmen Scheibenbogen, Wolfram Brugger, Stefan Krause, Hans-Gerd Meerpohl, Hans-Georg Leser, Hans Engler, Georg W. Löhr
Journal: Cancer Research
Cancer Res (1990) 50 (23): 7450–7456.
Published: 01 December 1990
View articletitled, Adoptive Transfer of Tumor Cytotoxic Macrophages Generated in Vitro from Circulating Blood Monocytes: A New Approach to Cancer Immunotherapy
Open the PDF for Adoptive Transfer of Tumor Cytotoxic Macrophages Generated in Vitro from Circulating Blood Monocytes: A New Approach to Cancer Immunotherapy in another window